1.Smith & Nephew plc is the parent company of Group. It is an English public limited company with public liability and its shares are listed on the UK Listing Authority's list and are listed on the London Stock Exchange. Schlafly Group is a global medical device business with advanced orthopedic reconstruction, bedside and sports wound management, which brought in approximately $4.6 billion in revenue in 2014. Smith & Nephew has distribution channels in 90 countries worldwide. In countries where tax revenues are more mature, the company's business operations are mainly run by divisions. In most of the remaining markets, operations are run primarily by country executives responsible for selling and distributing the entire product line. These include emerging markets and international markets. Incorporated in 1937, Xerox Fairey was incorporated on the London Stock Exchange and listed on the New York Stock Exchange in 1999.
2. Schlafly is a leading global medical products company headquartered in London, England. Founded in 1856, the company now employs more than 9,000 people in 33 countries and has annual sales of $3.8 billion. Nephew Smith is committed to the development and marketing of advanced medical devices that help specialized medical institutions take more effective measures to treat patients and help them recover faster and return to normal life. The four Global Business Units (GBUs) - Orthopedics, Endoscopy, BioSpine and Wound Care - are focused on developing cost-effective, innovative products to meet increasingly pressing healthcare needs. All four GBUs are industry leaders: Endoscopy is No. 1 in the world; Orthopaedic Trauma is ranked No. 2 in the world; and Wound Care is a world leader. smith & nephew entered China in 1994 with offices in Shanghai, Beijing and Guangzhou. in 1999, the first wholly-owned subsidiary in China was established in the Waigaoqiao Free Trade Zone in Shanghai --Ltd. in Shanghai Waigaoqiao Free Trade Zone. The company was incorporated on November 26, 2007 in Suzhou.